Abstract:Hepatocellular carcinoma (HCC) is one of the most commonly seen liver disease. Most of HCC patients are diagnosed as Hepatitis B related cirrhosis simultaneously, especially in Asian countries. HCC is the fifth most common cancer and the second most common cause of cancer-related death in the World. HCC incidence rates have been rising in the past 3 decades, and it is expected to be doubled by 2030, if there is no effective means for its early diagnosis and management. The improvement of patient's care, research, and policy is significantly based on accurate medical diagnosis, especially for malignant tumor patients. However, sometimes it is really difficult to get access to advanced and expensive diagnostic tools such as computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET-CT)., especially for people who resides in poverty-stricken area. Therefore, experts are searching for a framework for predicting of early liver diseases based on basic and simple examinations such as biochemical and routine blood tests, which are easily accessible all around the World. Disease identification and classification has been significantly enhanced by using artificial intelligence (AI) and machine learning (ML) in conjunction with clinical data. The goal of this research is to extract the most significant risk factors or clinical parameters for liver diseases in 525 patients based on clinical experience using machine learning algorithms, such as regularized regression (RR), logistic regression (LR), random forest (RF), decision tree (DT), and extreme gradient boosting (XGBoost). The results showed that RF classier had the best performance (accuracy = 0.762, recall = 0.843, F1-score = 0.775, and AUC = 0.999) among the five ML algorithms. And the important orders of 14 significant risk factors are as follows: Total bilirubin, gamma-glutamyl transferase (GGT), direct bilirubin, hemoglobin, age, platelet, alkaline phosphatase (ALP), aspartate transaminase (AST), creatinine, alanine aminotransferase (ALT), cholesterol, albumin, urea nitrogen, and white blood cells. ML classifiers might aid medical organizations in the early detection and classification of liver disease, which would be beneficial in low-income regions, and the relevance of risk factors would be helpful in the prevention and treatment of liver disease patients.

Intelligent Model to Predict Early Liver Disease using Machine Learning Technique

Machine Learning with Abstention for Automated Liver Disease Diagnosis

A framework for identification and classification of liver diseases based on machine learning algorithms

Enhanced Preprocessing Approach Using Ensemble Machine Learning Algorithms for Detecting Liver Disease

Application of Machine Learning Techniques for Clinical Predictive Modeling: A Cross-Sectional Study on Nonalcoholic Fatty Liver Disease in China

Liver Infection Prediction Analysis using Machine Learning to Evaluate Analytical Performance in Neural Networks by Optimization Techniques

Hybrid XGBoost model with hyperparameter tuning for prediction of liver disease with better accuracy

Machine Learning Algorithms Based Non Alcoholic Fatty Liver Disease Prediction

Machine Learning Approaches for Binary Classification to Discover Liver Diseases using Clinical Data

Improved liver disease prediction from clinical data through an evaluation of ensemble learning approaches

Data driven intelligent model for quality management in healthcare

Application of Machine Learning for Diagnosis of Liver Cancer

A self-predictive diagnosis system of liver failure based on multilayer neural networks

Application of machine learning in predicting non-alcoholic fatty liver disease using anthropometric and body composition indices

An artificial neural network approach to diagnose and predict liver dysfunction and failure in the critical care setting

Machine Learning-Based Diagnosis and Detection of Liver Cancer: An Approach Enhancement

Prediction of Fatty Liver Disease in a Chinese Population Using Machine-Learning Algorithms

Machine learning approaches for early detection of non-alcoholic steatohepatitis based on clinical and blood parameters

A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease

Machine-Learning Algorithm for Predicting Fatty Liver Disease in a Taiwanese Population

Early heart disease prediction using feature engineering and machine learning algorithms